trial

Emotion Endophenotypes in Schizophrenia

NCTId NCT02834208
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 105 (estimated)
Sponsored by Assistance Publique Hopitaux De Marseille
Primary completion 2018-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
105 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2015-12
Primary completion
2018-12
Eligibility
ALL · 18 Years · 45 Years

Interventions & indications

Drugs
MRI (Magnetic resonance imaging)Polymorphism (SNP in DNA)quantitative measures of mRNANeuropsychological assessment

Sponsors

Assistance Publique Hopitaux De MarseilleLead Sponsor

Investigators

1
Catherine GEINDREStudy Director

Sites

1 total
Marseille, France

Facts & assertions

4 sourced
Enrollment
105
Phase
NA
Primary Completion Date
2018-12
Status
UNKNOWN
relationships
The graph out of here
drug
MRI (Magnetic resonance imaging)
drug
Polymorphism (SNP in DNA)
drug
quantitative measures of mRNA
drug
Neuropsychological assessment
drug
lead_sponsor
Assistance Publique Hopitaux De Marseille
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Catherine GEINDRE
person